CGH
SUPN icon

Crossmark Global Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

Crossmark Global Holdings’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Hold
4,798
– – ﹤0.01% 1191
2026
Q1 		$248K Buy
4,798
+161
+3% +$8.2K ﹤0.01% 1105
2025
Q4 		$230K Buy
+4,637
New +$225K ﹤0.01% 1132
2021
Q4 		– Sell
-18,080
Closed -$482K – 1463
2021
Q3 		$482K Sell
18,080
-60
-0.3% -$1.61K 0.01% 940
2021
Q2 		$559K Buy
18,140
+40
+0.2% +$1.23K 0.01% 859
2021
Q1 		$474K Buy
18,100
+1,580
+10% +$44.2K 0.01% 928
2020
Q4 		$416K Buy
+16,520
New +$356K 0.01% 925
2019
Q4 		– Sell
-12,530
Closed -$344K – 1436
2019
Q3 		$344K Sell
12,530
-160
-1% -$4.74K 0.01% 979
2019
Q2 		$420K Sell
12,690
-930
-7% -$31.9K 0.01% 903
2019
Q1 		$477K Sell
13,620
-60
-0.4% -$2.23K 0.01% 840
2018
Q4 		$454K Sell
13,680
-3,580
-21% -$154K 0.01% 803
2018
Q3 		$869K Sell
17,260
-720
-4% -$35.6K 0.02% 665
2018
Q2 		$1.08M Buy
17,980
+760
+4% +$39.4K 0.03% 567
2018
Q1 		$789K Sell
17,220
-1,650
-9% -$68.9K 0.02% 690
2017
Q4 		$752K Sell
18,870
-2,580
-12% -$102K 0.02% 756
2017
Q3 		$858K Buy
+21,450
New +$928K 0.02% 674
2016
Q3 		$858K Buy
+21,450
New +$485K 0.02% 674

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Crossmark Global Holdings's SUPN Position: Q2 2026 in Review

Crossmark Global Holdings held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 4,798 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Crossmark Global Holdings first reported a position in SUPN in Q3 2016 and has held it in 17 quarters since. The position peaked at $1.08M in Q2 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Crossmark Global Holdings held 4,798 shares of Supernus Pharmaceuticals worth $223K as of Q2 2026.
  • Crossmark Global Holdings left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1191 holding.
  • Crossmark Global Holdings first reported a position in Supernus Pharmaceuticals in Q3 2016 and has held it in 17 quarters since.
  • Crossmark Global Holdings's Supernus Pharmaceuticals position peaked at $1.08M in Q2 2018.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.